BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25393090)

  • 1. Combination topical therapy for conjunctival primary acquired melanosis with atypia and periocular lentigo maligna.
    Bratton EM; Knutsen-Larson S; Durairaj VD; Gregory DG; Mellette JR
    Cornea; 2015 Jan; 34(1):90-3. PubMed ID: 25393090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical imiquimod for periocular lentigo maligna.
    Demirci H; Shields CL; Bianciotto CG; Shields JA
    Ophthalmology; 2010 Dec; 117(12):2424-9. PubMed ID: 20591492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna.
    Bassukas ID; Gamvroulia C; Zioga A; Nomikos K; Fotika C
    Int J Dermatol; 2008 May; 47(5):519-21. PubMed ID: 18412875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
    Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
    J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
    Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
    J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
    Nadiminti H; Scope A; Marghoob AA; Busam K; Nehal KS
    Dermatol Surg; 2010 Feb; 36(2):177-84. PubMed ID: 20039914
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical usefulness of dermoscopy in the management of lentigo maligna melanoma treated with topical imiquimod: A case report.
    Hamilko de Barros M; Conforti C; Giuffrida R; Seabra Resende FS; Di Meo N; Zalaudek I
    Dermatol Ther; 2019 Sep; 32(5):e13048. PubMed ID: 31365164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
    de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
    Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
    [No Abstract]   [Full Text] [Related]  

  • 11. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous occurrence of multiple melanoma in situ on sun-damaged skin (lentigo maligna), solar lentigo and labial melanosis: the value of dermoscopy in diagnosis.
    Massi D; Nardini P; De Giorgi V; Carli P
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):193-7. PubMed ID: 10642055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelanotic lentigo maligna managed with topical imiquimod.
    Lapresta A; García-Almagro D; Sejas AG
    J Dermatol; 2012 May; 39(5):503-5. PubMed ID: 21973079
    [No Abstract]   [Full Text] [Related]  

  • 15. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
    Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
    Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
    [No Abstract]   [Full Text] [Related]  

  • 16. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
    Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream.
    Borucki U; Metze D
    Dermatology; 2003; 207(3):326-8. PubMed ID: 14571081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dubreuilh melanoma(lentigo maligna melanoma)].
    Ollivaud L; Basset-Seguin N; Archimbaud A
    Ann Dermatol Venereol; 2001 Feb; 128(2):172-6. PubMed ID: 11275603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conjunctival primary acquired melanosis].
    Krohn J; Monge OR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.